[go: up one dir, main page]

MX2010005597A - Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos. - Google Patents

Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos.

Info

Publication number
MX2010005597A
MX2010005597A MX2010005597A MX2010005597A MX2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A
Authority
MX
Mexico
Prior art keywords
compositions
peptide
immunoregulatory peptides
novel immunoregulatory
novel
Prior art date
Application number
MX2010005597A
Other languages
English (en)
Inventor
Vladislav Deigin
Original Assignee
Immunotech Dev Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Dev Inc filed Critical Immunotech Dev Inc
Publication of MX2010005597A publication Critical patent/MX2010005597A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe un péptido biológicamente activo de formula (1) [X-L y Glu-trp-y], una composición farmacéutica novedosa que contiene el péptido, un método para preparar el péptido y usos del mismo.
MX2010005597A 2007-11-20 2008-11-20 Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos. MX2010005597A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98928007P 2007-11-20 2007-11-20
PCT/CA2008/002037 WO2009065217A1 (en) 2007-11-20 2008-11-20 Novel immunoregulatory peptides, compositions and uses thereof

Publications (1)

Publication Number Publication Date
MX2010005597A true MX2010005597A (es) 2010-10-25

Family

ID=40667077

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005597A MX2010005597A (es) 2007-11-20 2008-11-20 Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos.

Country Status (9)

Country Link
US (1) US20110003751A1 (es)
JP (1) JP2011503215A (es)
AU (1) AU2008328485B2 (es)
BR (1) BRPI0820659A2 (es)
CA (1) CA2706525C (es)
IL (1) IL205843A0 (es)
MX (1) MX2010005597A (es)
WO (1) WO2009065217A1 (es)
ZA (1) ZA201006443B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102724998A (zh) 2009-08-10 2012-10-10 伊姆诺科技发展公司 用于引发特异性免疫应答以治疗病毒感染和其他病症的具有肽佐剂的疫苗
AU2012234689A1 (en) * 2011-03-31 2013-10-17 Apotex Technologies Inc. Prodrugs of D-gamma-glutamyl-D-tryptophan and D-gamma- glutamyl-L-tryptophan
CN116688353A (zh) 2016-12-01 2023-09-05 领先仿生公司 触点阵列组件、耳蜗植入物及形成耳蜗植入物电极阵列的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2107691C1 (ru) * 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
WO1997019691A1 (en) * 1995-11-28 1997-06-05 Wei, Edward, T. Gamma-l-glutamyl containing immunomodulator compounds and methods therewith
US6159940A (en) * 1996-02-28 2000-12-12 Immunotech Developments Inc. Method for modulating hemopoiesis

Also Published As

Publication number Publication date
US20110003751A1 (en) 2011-01-06
BRPI0820659A2 (pt) 2019-09-24
JP2011503215A (ja) 2011-01-27
CA2706525A1 (en) 2009-05-28
ZA201006443B (en) 2011-12-28
AU2008328485A1 (en) 2009-05-28
IL205843A0 (en) 2010-11-30
CA2706525C (en) 2012-05-01
WO2009065217A1 (en) 2009-05-28
AU2008328485B2 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
UA96449C2 (en) Stable laquinimod preparations
GB2431404A (en) Peptide
EP2583976A3 (en) Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens
MX2009005461A (es) N-oxidos de analogos de 4,5-epoxi-morfinano.
WO2007043048A3 (en) Self-assembled fmoc-ff hydrogels
WO2008136865A3 (en) (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
MY148844A (en) Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
PL1791571T3 (pl) Radiofluorowane peptydy
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
ZA200807027B (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
TW200626553A (en) Novel compounds
WO2008101173A3 (en) Biodegradable compositions and materials
MXPA05010613A (es) Formulacion parenteral de acido micofenolico, una sal o profarmaco del mismo.
TW200605888A (en) Novel compounds
MX2010005597A (es) Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos.
UA95253C2 (ru) Соединения аналога камптотецина, способ их получения и фармацевтическая композиция, которая их содержит
WO2010057275A8 (en) Cyclic peptides and uses thereof
WO2007015918A3 (en) Novel biologically active peptides and their new uses
WO2005105832A3 (en) Biologically active peptide vapeehptllteaplnpk derivatives
MY144748A (en) Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
HK1094972A (en) Biologically active peptide vapeehptllteaplnpk derivatives
UA95254C2 (ru) Соединения аналога камптотецина, способ их получения и фармацевтическая композиция, которая их содержит
TW200633717A (en) Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents

Legal Events

Date Code Title Description
FG Grant or registration